Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP10 | Q53GL7 | 5/20 | 0.78 |
| ▸ | CA1 | P00915 | 5/20 | 0.78 |
| ▸ | CA2 | P00918 | 5/20 | 0.78 |
| ▸ | PARP4 | Q9UKK3 | 2/20 | 0.78 |
| ▸ | PARP1 | P09874 | 2/20 | 0.78 |
| ▸ | PARP2 | Q9UGN5 | 1/20 | 0.78 |
| ▸ | PTGIR | P43119 | 1/20 | 0.69 |
| ▸ | CHEK2 | O96017 | 2/20 | 0.56 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | PARP15 | Q460N3 | 1/20 | 0.53 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.53 |
| ▸ | PARP16 | Q8N5Y8 | 1/20 | 0.53 |
| ▸ | PARP11 | Q9NR21 | 1/20 | 0.53 |
| ▸ | CES2 | O00748 | 1/20 | 0.53 |
| ▸ | CES1 | P23141 | 1/20 | 0.53 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.50 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.50 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL201761 | 0.88 | PARP10 (1.00) | PARP10CA1CA2PARP4PARP1 | |
| Hydrochloric Acid SCHEMBL4376056 | 0.86 | PARP10 (0.95) | PARP10CA1CA2PARP4PARP1 | |
| Hydrochloric Acid SCHEMBL408766 | 0.86 | PARP10 (0.95) | PARP10CA1CA2PARP4PARP1 | |
| SCHEMBL6932815 | 0.83 | CA1 (0.77) | PARP10CA1CA2PARP4PARP1 | |
| SCHEMBL5451478 | 0.83 | HPGD (0.73) | PARP10CA1CA2PARP4PARP1 | |
| Acetic Acid SCHEMBL28396208 | 0.82 | PARP10 (0.88) | PARP10CA1CA2PARP4PARP1 | |
| SCHEMBL7442028 | 0.82 | PARP10 (0.88) | PARP10CA1CA2PARP4PARP1 | |
| SCHEMBL27571315 | 0.82 | PARP10 (0.88) | PARP10CA1CA2PARP4PARP1 | |
| SCHEMBL5836337 | 0.82 | PARP10 (1.00) | PARP10CA1CA2PARP4PARP1 | |
| SCHEMBL5788625 | 0.81 | PTGIR (1.00) | PARP10CA1CA2PARP4PARP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2005047237-A1 | METHOD FOR SYNTHESISING DIARYL SULPHIDE COMPOUNDS IN A SOLID PHASE | GALDERMA RESEARCH & DEVELOPMENT, S.N.C. (FR) | 2005-05-26 | — | — | WO | claimed |
| US-11427536-B2 | Photocatalyst-free, light-induced carbon-sulfur cross-coupling methods | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) | 2022-08-30 | — | — | US | disclosed |
| US-20180370911-A1 | PHOTOCATALYST-FREE, LIGHT-INDUCED CARBON-SULFUR CROSS-COUPLING METHODS | U.S. DEPARTMENT OF ENERGY | 2018-12-27 | — | — | US | disclosed |
| WO-2005047237-A1 | METHOD FOR SYNTHESISING DIARYL SULPHIDE COMPOUNDS IN A SOLID PHASE | GALDERMA RESEARCH & DEVELOPMENT, S.N.C. (FR) | 2005-05-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180370911-A1 | PHOTOCATALYST-FREE, LIGHT-INDUCED CARBON-SULFUR CROSS-COUPLING METHODS | TST, CBS, CRY2 | PARP10 1505/4885CA1 1959/4885CA2 1285/4885 |
| US-11427536-B2 | Photocatalyst-free, light-induced carbon-sulfur cross-coupling methods | TST, CBS, CRY2 | PARP10 1505/4885CA1 1959/4885CA2 1285/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.